Cover

Loading…
More Information
Summary:The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of TRPC4. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding TRPC4.
Bibliography:Application Number: US20040500493